Carmine N. Stengone - Net Worth and Insider Trading
Carmine N. Stengone Net Worth
The estimated net worth of Carmine N. Stengone is at least $4,525 dollars as of 2024-11-13. Carmine N. Stengone is the Director of Kiora Pharmaceuticals Inc and owns about 1,250 shares of Kiora Pharmaceuticals Inc (KPRX) stock worth over $4,525. Details can be seen in Carmine N. Stengone's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carmine N. Stengone has not made any transactions after 2024-09-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Carmine N. Stengone
Carmine N. Stengone Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carmine N. Stengone owns 1 companies in total, including Kiora Pharmaceuticals Inc (KPRX) .
Click here to see the complete history of Carmine N. Stengone’s form 4 insider trades.
Insider Ownership Summary of Carmine N. Stengone
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPRX | Kiora Pharmaceuticals Inc | 2024-09-11 | director |
Carmine N. Stengone Latest Holdings Summary
Carmine N. Stengone currently owns a total of 1 stock. Carmine N. Stengone owns 1,250 shares of Kiora Pharmaceuticals Inc (KPRX) as of September 11, 2024, with a value of $4,525.
Latest Holdings of Carmine N. Stengone
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KPRX | Kiora Pharmaceuticals Inc | 2024-09-11 | 1,250 | 3.62 | 4,525 |
Holding Weightings of Carmine N. Stengone
Carmine N. Stengone Form 4 Trading Tracker
According to the SEC Form 4 filings, Carmine N. Stengone has made a total of 1 transactions in Kiora Pharmaceuticals Inc (KPRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kiora Pharmaceuticals Inc is the acquisition of 1,250 shares on September 11, 2024, which cost Carmine N. Stengone around $4,600.
Insider Trading History of Carmine N. Stengone
- 1
Carmine N. Stengone Trading Performance
GuruFocus tracks the stock performance after each of Carmine N. Stengone's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Carmine N. Stengone is %. GuruFocus also compares Carmine N. Stengone's trading performance to market benchmark return within the same time period. The performance of stocks bought by Carmine N. Stengone within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Carmine N. Stengone's insider trading performs compared to the benchmark.
Performance of Carmine N. Stengone
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.91 |  | | | | |
| Relative Return to S&P 500(%) | -8.61 | | | | | |
Carmine N. Stengone Ownership Network
Ownership Network List of Carmine N. Stengone
Ownership Network Relation of Carmine N. Stengone
Carmine N. Stengone Owned Company Details
What does Kiora Pharmaceuticals Inc do?
Who are the key executives at Kiora Pharmaceuticals Inc?
Carmine N. Stengone is the director of Kiora Pharmaceuticals Inc. Other key executives at Kiora Pharmaceuticals Inc include EVP of Finance Melissa Tosca , Chief Development Officer Eric Joseph Daniels , and director & President and CEO Brian M. Strem .
Kiora Pharmaceuticals Inc (KPRX) Insider Trades Summary
Over the past 18 months, Carmine N. Stengone made 1 insider transaction in Kiora Pharmaceuticals Inc (KPRX) with a net purchase of 1,250. Other recent insider transactions involving Kiora Pharmaceuticals Inc (KPRX) include a net purchase of 2,100 shares made by Melissa Tosca , a net purchase of 5,260 shares made by Erin Parsons , and a net purchase of 5,000 shares made by Praveen Tyle .
In summary, during the past 3 months, insiders sold 0 shares of Kiora Pharmaceuticals Inc (KPRX) in total and bought 12,500 shares, with a net purchase of 12,500 shares. During the past 18 months, 0 shares of Kiora Pharmaceuticals Inc (KPRX) were sold and 22,291 shares were bought by its insiders, resulting in a net purchase of 22,291 shares.
Kiora Pharmaceuticals Inc (KPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiora Pharmaceuticals Inc Insider Transactions
Carmine N. Stengone Mailing Address
Above is the net worth, insider trading, and ownership report for Carmine N. Stengone. You might contact Carmine N. Stengone via mailing address: 10578 Science Center Drive, Suite 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
